<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02102386</url>
  </required_header>
  <id_info>
    <org_study_id>201312041</org_study_id>
    <nct_id>NCT02102386</nct_id>
  </id_info>
  <brief_title>Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries</brief_title>
  <acronym>CerOx</acronym>
  <official_title>Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to demonstrate Or-Nim's CerOx monitor ability to monitor changes in&#xD;
      cerebral blood flow and oximetry during CEA surgery.&#xD;
&#xD;
      Procedures include:&#xD;
&#xD;
      Screening:&#xD;
&#xD;
      ECG, blood draw, neurological assessment, NIHSS&#xD;
&#xD;
      study: CerOX and TCD clock during CEA procedure, data collection from the medical&#xD;
      record/monitors, neurological assessment, NIHSS&#xD;
&#xD;
      30 day follow-up&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Technical issues with the device under study. Sponsor terminated.&#xD;
  </why_stopped>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>compare cerebral perfusion and Oximetry changes to arterial blood pressure and trans-cranial doppler velocity changes</measure>
    <time_frame>up to 3 hours</time_frame>
    <description>compare cerebral perfusion and Oximetry changes to arterial blood pressure and trans-cranial doppler velocity changes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>to compare cerebral perfusion and oximetry changes to non-invasive cardiac output, and systemic vascular resistances changes.</measure>
    <time_frame>up to 3 hours</time_frame>
    <description>to compare cerebral perfusion and oximetry changes to non-invasive cardiac output, and systemic vascular resistances changes.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">13</enrollment>
  <condition>Carotid Endarterectomy</condition>
  <arm_group>
    <arm_group_label>CerOx</arm_group_label>
    <description>Patients will be monitored using the CerOx monitor. Probes will be attached bi-laterally in the OR to the forehead.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled to undergo elective carotid endarterectomy at Barnes Jewish Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Patients scheduled to undergo a CEA procedure that have consented to participate in the&#xD;
        study will be included in this observational study.&#xD;
&#xD;
        Research Subjects: Indications for monitoring include patients scheduled for CEA that&#xD;
        comply with the inclusion and exclusion criteria.&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
        To be considered eligible to participate in this study, a patient must meet the inclusion&#xD;
        criteria listed below:&#xD;
&#xD;
        1. Consenting patients over 18 years, undergoing elective carotid endarterectomy at Barnes&#xD;
        Jewish Hospital.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        To be eligible for entry into the study, the patient must not meet any of the exclusion&#xD;
        criteria listed below:&#xD;
&#xD;
          1. Emergency surgery&#xD;
&#xD;
          2. National Institute of health Stroke Scale (NIHSS) score &gt;=10&#xD;
&#xD;
          3. Sub-cutaneous hematoma at the ipsilateral intended area of the CerOx probe location.&#xD;
&#xD;
          4. Laceration or scalp injury at the ipsilateral intended area of the CerOx probe&#xD;
             location which contraindicates placement of the adhesive on the skin.&#xD;
&#xD;
          5. Patient with implants located in the intended area of the CerOx probe location.&#xD;
&#xD;
          6. Prisoners&#xD;
&#xD;
          7. Non-consenting patient Or non-participating surgeon schedule of assessments and&#xD;
             procedures&#xD;
&#xD;
          8. Pregnant or lactating women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivan Kangrga, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington Univesity School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Vannucci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <study_first_submitted>March 29, 2014</study_first_submitted>
  <study_first_submitted_qc>April 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2014</study_first_posted>
  <last_update_submitted>January 27, 2015</last_update_submitted>
  <last_update_submitted_qc>January 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington University School of Medicine</investigator_affiliation>
    <investigator_full_name>kangrga</investigator_full_name>
    <investigator_title>Clinical Chief Director, Abdominal Organ Transplant</investigator_title>
  </responsible_party>
  <keyword>elective</keyword>
  <keyword>carotid endarterectomy surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

